Gespeichert in:
Titel: | Plant-Based Therapeutics, Volume 1 Cannabis sativa / |
---|---|
Von: |
by Ivan A. Ross.
|
Person: |
Ross, Ivan A.
author. aut http://id.loc.gov/vocabulary/relators/aut |
Hauptverfasser: | |
Körperschaft: | |
Format: | Elektronisch E-Book |
Sprache: | Englisch |
Veröffentlicht: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
Ausgabe: | 1st ed. 2023. |
Schlagwörter: | |
Medienzugang: | https://doi.org/10.1007/978-3-031-35155-6 |
Zusammenfassung: | By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest in herbal medicine for wellness and health. Plant-Based Therapeutics, Volume 1: Cannabis sativa, the first in the series, covers a unique plant species and provides the framework to integrate its evidence-based scientific discoveries with healthcare therapies. Cannabis has been used in religious ceremonies and medical purposes for thousands of years. Cannabidiol (CBD), the main non-psychoactive component of Cannabis, was isolated in the 1940s, and its structure was established in the 1960s. In 1964 tetrahydrocannabinol (THC), the psychoactive component, was isolated. Cannabis has more than 500 components, of which 104 cannabinoids have been identified. Two of them, THC and CBD, have been the primary components of scientific investigations. They were approved by the FDA for chemotherapy-induced nausea and vomiting in 1985; for appetite stimulation in wasting conditions, such as AIDS, in 1992, and in 2018 for treating two forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Beyond the indications for which cannabinoids are FDA-approved, the evidence reveals that cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Thus, other constituents of Cannabis are extremely promising either as individual compounds or their potential synergistic or entourage effects in the treatment of numerous medical conditions. . |
Umfang: | 1 Online-Ressource (XXI, 657 p.) |
ISBN: | 9783031351556 |
Internformat
MARC
LEADER | 00000nam a22000005i 4500 | ||
---|---|---|---|
001 | ZDB-2-SBL-978-3-031-35155-6 | ||
003 | DE-He213 | ||
005 | 20230808023038.0 | ||
007 | cr nn 008mamaa | ||
008 | 230808s2023 sz | o |||| 0|eng d | ||
020 | |a 9783031351556 |9 978-3-031-35155-6 | ||
024 | 7 | |a 10.1007/978-3-031-35155-6 |2 doi | |
050 | 4 | |a QK | |
072 | 7 | |a PST |2 bicssc | |
072 | 7 | |a SCI011000 |2 bisacsh | |
072 | 7 | |a PST |2 thema | |
082 | 7 | |a 580 |2 23 | |
100 | 1 | |a Ross, Ivan A. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
245 | 1 | 0 | |a Plant-Based Therapeutics, Volume 1 |h [electronic resource] : |b Cannabis sativa / |c by Ivan A. Ross. |
250 | |a 1st ed. 2023. | ||
264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2023. | |
300 | |a 1 Online-Ressource (XXI, 657 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file |b PDF |2 rda | ||
505 | 0 | |a Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson's disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation. | |
520 | |a By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest in herbal medicine for wellness and health. Plant-Based Therapeutics, Volume 1: Cannabis sativa, the first in the series, covers a unique plant species and provides the framework to integrate its evidence-based scientific discoveries with healthcare therapies. Cannabis has been used in religious ceremonies and medical purposes for thousands of years. Cannabidiol (CBD), the main non-psychoactive component of Cannabis, was isolated in the 1940s, and its structure was established in the 1960s. In 1964 tetrahydrocannabinol (THC), the psychoactive component, was isolated. Cannabis has more than 500 components, of which 104 cannabinoids have been identified. Two of them, THC and CBD, have been the primary components of scientific investigations. They were approved by the FDA for chemotherapy-induced nausea and vomiting in 1985; for appetite stimulation in wasting conditions, such as AIDS, in 1992, and in 2018 for treating two forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Beyond the indications for which cannabinoids are FDA-approved, the evidence reveals that cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Thus, other constituents of Cannabis are extremely promising either as individual compounds or their potential synergistic or entourage effects in the treatment of numerous medical conditions. . | ||
650 | 0 | |a Botany. | |
650 | 0 | |a Alternative medicine. | |
650 | 0 | |a Pharmacology. | |
650 | 0 | |a Medicinal chemistry. | |
650 | 0 | |a Physiology. | |
650 | 0 | |a Agriculture. | |
650 | 1 | 4 | |a Plant Science. |
650 | 2 | 4 | |a Complementary and Alternative Medicine. |
650 | 2 | 4 | |a Pharmacology. |
650 | 2 | 4 | |a Medicinal Chemistry. |
650 | 2 | 4 | |a Physiology. |
650 | 2 | 4 | |a Agriculture. |
710 | 2 | |a SpringerLink (Online service) | |
773 | 0 | |t Springer Nature eBook | |
776 | 0 | 8 | |i Printed edition: |z 9783031351549 |
776 | 0 | 8 | |i Printed edition: |z 9783031351563 |
776 | 0 | 8 | |i Printed edition: |z 9783031351570 |
966 | 4 | 0 | |l DE-355 |p ZDB-2-SBL |q UBG_PDA_SBL |u https://doi.org/10.1007/978-3-031-35155-6 |3 Volltext |
912 | |a ZDB-2-SBL | ||
912 | |a ZDB-2-SXB | ||
950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
912 | |a ZDB-2-SBL | ||
049 | |a DE-355 |
Datensatz im Suchindex
DE-BY-UBR_katkey | ZDB-2-SBL-978-3-031-35155-6 |
---|---|
_version_ | 1835726563840098304 |
adam_text | |
any_adam_object | |
author | Ross, Ivan A. |
author_corporate | SpringerLink (Online service) |
author_corporate_role | |
author_facet | Ross, Ivan A. SpringerLink (Online service) |
author_role | aut |
author_sort | Ross, Ivan A. |
author_variant | i a r ia iar |
building | Verbundindex |
bvnumber | localUBR |
callnumber-first | Q - Science |
callnumber-label | QK |
callnumber-raw | QK |
callnumber-search | QK |
callnumber-sort | QK |
callnumber-subject | QK - Botany |
collection | ZDB-2-SBL ZDB-2-SXB |
contents | Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson's disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation. |
dewey-full | 580 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 580 - Plants |
dewey-raw | 580 |
dewey-search | 580 |
dewey-sort | 3580 |
dewey-tens | 580 - Plants |
discipline | Biologie |
edition | 1st ed. 2023. |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04298nam a22005655i 4500</leader><controlfield tag="001">ZDB-2-SBL-978-3-031-35155-6</controlfield><controlfield tag="003">DE-He213</controlfield><controlfield tag="005">20230808023038.0</controlfield><controlfield tag="007">cr nn 008mamaa</controlfield><controlfield tag="008">230808s2023 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031351556</subfield><subfield code="9">978-3-031-35155-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-35155-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QK</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PST</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SCI011000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PST</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">580</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ross, Ivan A.</subfield><subfield code="e">author.</subfield><subfield code="4">aut</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Plant-Based Therapeutics, Volume 1</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Cannabis sativa /</subfield><subfield code="c">by Ivan A. Ross.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2023.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXI, 657 p.) </subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson's disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest in herbal medicine for wellness and health. Plant-Based Therapeutics, Volume 1: Cannabis sativa, the first in the series, covers a unique plant species and provides the framework to integrate its evidence-based scientific discoveries with healthcare therapies. Cannabis has been used in religious ceremonies and medical purposes for thousands of years. Cannabidiol (CBD), the main non-psychoactive component of Cannabis, was isolated in the 1940s, and its structure was established in the 1960s. In 1964 tetrahydrocannabinol (THC), the psychoactive component, was isolated. Cannabis has more than 500 components, of which 104 cannabinoids have been identified. Two of them, THC and CBD, have been the primary components of scientific investigations. They were approved by the FDA for chemotherapy-induced nausea and vomiting in 1985; for appetite stimulation in wasting conditions, such as AIDS, in 1992, and in 2018 for treating two forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Beyond the indications for which cannabinoids are FDA-approved, the evidence reveals that cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Thus, other constituents of Cannabis are extremely promising either as individual compounds or their potential synergistic or entourage effects in the treatment of numerous medical conditions. .</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Botany.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Alternative medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicinal chemistry.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Physiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Agriculture.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Plant Science.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Complementary and Alternative Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Medicinal Chemistry.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Physiology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Agriculture.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">SpringerLink (Online service)</subfield></datafield><datafield tag="773" ind1="0" ind2=" "><subfield code="t">Springer Nature eBook</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031351549</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031351563</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031351570</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">UBG_PDA_SBL</subfield><subfield code="u">https://doi.org/10.1007/978-3-031-35155-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SXB</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (SpringerNature-11642)</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (R0) (SpringerNature-43708)</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield></record></collection> |
id | ZDB-2-SBL-978-3-031-35155-6 |
illustrated | Not Illustrated |
indexdate | 2025-06-23T13:27:55Z |
institution | BVB |
isbn | 9783031351556 |
language | English |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XXI, 657 p.) |
psigel | ZDB-2-SBL UBG_PDA_SBL ZDB-2-SBL ZDB-2-SXB |
publishDate | 2023 |
publishDateSearch | 2023 |
publishDateSort | 2023 |
publisher | Springer International Publishing : Imprint: Springer, |
record_format | marc |
spelling | Ross, Ivan A. author. aut http://id.loc.gov/vocabulary/relators/aut Plant-Based Therapeutics, Volume 1 [electronic resource] : Cannabis sativa / by Ivan A. Ross. 1st ed. 2023. Cham : Springer International Publishing : Imprint: Springer, 2023. 1 Online-Ressource (XXI, 657 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson's disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation. By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest in herbal medicine for wellness and health. Plant-Based Therapeutics, Volume 1: Cannabis sativa, the first in the series, covers a unique plant species and provides the framework to integrate its evidence-based scientific discoveries with healthcare therapies. Cannabis has been used in religious ceremonies and medical purposes for thousands of years. Cannabidiol (CBD), the main non-psychoactive component of Cannabis, was isolated in the 1940s, and its structure was established in the 1960s. In 1964 tetrahydrocannabinol (THC), the psychoactive component, was isolated. Cannabis has more than 500 components, of which 104 cannabinoids have been identified. Two of them, THC and CBD, have been the primary components of scientific investigations. They were approved by the FDA for chemotherapy-induced nausea and vomiting in 1985; for appetite stimulation in wasting conditions, such as AIDS, in 1992, and in 2018 for treating two forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Beyond the indications for which cannabinoids are FDA-approved, the evidence reveals that cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Thus, other constituents of Cannabis are extremely promising either as individual compounds or their potential synergistic or entourage effects in the treatment of numerous medical conditions. . Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Physiology. Agriculture. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031351549 Printed edition: 9783031351563 Printed edition: 9783031351570 |
spellingShingle | Ross, Ivan A. Plant-Based Therapeutics, Volume 1 Cannabis sativa / Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson's disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation. Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Physiology. Agriculture. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
title | Plant-Based Therapeutics, Volume 1 Cannabis sativa / |
title_auth | Plant-Based Therapeutics, Volume 1 Cannabis sativa / |
title_exact_search | Plant-Based Therapeutics, Volume 1 Cannabis sativa / |
title_full | Plant-Based Therapeutics, Volume 1 [electronic resource] : Cannabis sativa / by Ivan A. Ross. |
title_fullStr | Plant-Based Therapeutics, Volume 1 [electronic resource] : Cannabis sativa / by Ivan A. Ross. |
title_full_unstemmed | Plant-Based Therapeutics, Volume 1 [electronic resource] : Cannabis sativa / by Ivan A. Ross. |
title_short | Plant-Based Therapeutics, Volume 1 |
title_sort | plant based therapeutics volume 1 cannabis sativa |
title_sub | Cannabis sativa / |
topic | Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Physiology. Agriculture. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
topic_facet | Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Physiology. Agriculture. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
work_keys_str_mv | AT rossivana plantbasedtherapeuticsvolume1cannabissativa AT springerlinkonlineservice plantbasedtherapeuticsvolume1cannabissativa |